Drug intelligence / Profile preview

hemp seed protein hydrolysate fraction F3

Development stage
Preclinical
Lead developer
University of Manitoba
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Hemp seed protein hydrolysate fraction F3 is a bioactive peptide-rich extract derived from the enzymatic hydrolysis of hemp seed (*Cannabis sativa* L.) protein isolate. It is typically produced through a sequential digestion process using pepsin and pancreatin to simulate human gastrointestinal digestion, achieving a degree of hydrolysis of approximately 48%. The resulting hydrolysate is then fractionated using ultrafiltration or chromatography. In a three-fraction separation system, F3 represents the high-molecular-weight component (typically >10 kDa). Preclinical research has identified this specific fraction as possessing the most potent antiproliferative activity among hemp protein derivatives, demonstrating significant growth inhibition in cancer cell lines such as Caco-2 (colorectal cancer) and THP-1 (leukemia). While lower molecular weight fractions exhibit higher antioxidant capacity, F3 is primarily characterized by its potential chemoprotective and antineoplastic properties, making it a subject of interest for functional food and nutraceutical applications in oncology.

Other names
hemp seed peptide fraction F3high-molecular-weight hemp protein hydrolysate fractionhemp seed protein hydrolysate fraction >10 kDa

Beyond the preview

Go deeper on hemp seed protein hydrolysate fraction F3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hemp seed protein hydrolysate fraction F3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call